Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CE1-C52H6 | Cynomolgus | Cynomolgus CEACAM-1 / CD66a Protein, His Tag | ![]() |
![]() ![]() |
|
CE1-H82E5 | Human | Biotinylated Human CEACAM-1 / CD66a Protein, Avitag™,His Tag | ![]() |
![]() ![]() |
![]() ![]() |
CE1-H5220 | Human | Human CEACAM-1 / CD66a Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized Human CEACAM-1, His Tag (Cat. No. CE1-H5220) at 10 μg/mL (100 μL/well) can bind Biotinylated Human CEACAM-8, His,Avitag (Cat. No. CE8-H82E9) with a linear range of 0.039-1.25 μg/mL (QC tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
CM-24 | CM-24 (MK-6018); MK-6018; CM-24 | Phase 2 Clinical | Merck Sharp & Dohme Corp | Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Thyroid Cancer, Papillary | Details |
This web search service is supported by Google Inc.